Lenalidomide G.L.

Medicinal product

(Invented) name

Lenalidomide G.L.

Active substance (s)

Lenalidomidas

Strength

15 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AX04, Lenalidomide

Marketing authorisation holder

G.L. Pharma GmbH, Austrija

Date of authorisation

2020-09-30

Date of renewal

Documents

4614_4617 Lenalidomide G_L PCS PL 2024 04 09.docx

Lenalidomide G.L mokomoji medziaga sveikatos prieziuros specialistams.pdf

Lenalidomide G.L_paciento brosiura.pdf

Lenalidomide G.L_nestumo pranesimo forma.pdf

Lenalidomide G.L_paciento kortele.pdf

4614_4617 Pakuotės lapelis 2024 04 09.docx

Lenalidomide G.L_sveikatos prieziuros specialisto kontrolinis sarasas.pdf

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

IS/H/0388/005/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Kapsulėje yra:	1 vnt.
Lenalidomidas	15 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
105082	91185	1091185	lizdinė plokštelė	N7		Receptinis	LT/1/20/4616/001	Netiekiama	-	-	No	-	-
105083	91186	1091186	lizdinė plokštelė	N21		Receptinis	LT/1/20/4616/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2020-09-30	Registruotas